Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea | Zendy

Ravi V. Shah | Zendy; Quynh A. Truong | Zendy; Hanna K. Gaggin | Zendy; Jens Pfannkuche | Zendy; Oliver Hartmann | Zendy; James L. Januzzi | Zendy

Open Access

Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea

Author(s) -

Ravi V. Shah,

Quynh A. Truong,

Hanna K. Gaggin,

Jens Pfannkuche,

Oliver Hartmann,

James L. Januzzi

Publication year - 2012

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehs136

Subject(s) - medicine , natriuretic peptide , cardiology , hazard ratio , heart failure , proportional hazards model , acute decompensated heart failure , logistic regression , emergency department , brain natriuretic peptide , odds ratio , confidence interval , psychiatry

The aim of this study was to assess diagnostic and prognostic value of mid-regional pro-atrial natriuretic peptide (MR-proANP) and adrenomedullin (MR-proADM) for the evaluation of patients presenting to the emergency department with acute dyspnoea.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research